Skip to content

Clinical effect of acupuncture and moxibustion combined with menstrual cycle therapy on regulating gonad axis function in patients with polycystic ovary syndrome

Clinical effect of acupuncture and moxibustion combined with menstrual cycle therapy on regulating gonad axis function in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070747
Enrollment
Unknown
Registered
2023-04-21
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

treatment group:Acupuncture and moxibustion

Sponsors

Teaching Hospital of Chengdu Universicity of T.C.M
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1 It conforms to PCOS diagnostic criteria. 2 Aged 20-40 years old. 3 Consistent with hyperandrogenemia. 4 Voluntary subjectsregular follow-upand sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1 Persons younger than 20 years old and older than 40 years old.2 Does not meet the western PCOS diagnostic standard or does not meet the Chinese medicine syndrome differentiation standard;3 Primary amenorrhea. 4 Other causes of hyperandrogen were excluded, such as congenital adrenal hyperplasia and Cushing's syndrome.5 Exclude other diseases that cause ovulation disorders, such as functional hypothalamic amenorrhea and early-onset ovarian dysfunction. 6 Abnormal menstruation caused by congenital malformation of reproductive organs or organic diseases. 7 Suffering from serious primary diseases of various systems.8 Malignant tumor.9 Diagnosed with serious mental illness.10 Those who have taken hormones, antiplatelet aggregation, antithrombotic drugs or participated in other clinical trials in the past month.

Design outcomes

Primary

MeasureTime frame
hormone;B-mode ultrasound;Ganyupixu syndrome score;

Secondary

MeasureTime frame
Ferriman-Gallway;Pillsbury;Self-Rating Anxiety Scale;Hamilton depression scale;Pittsburgh sleep quality index;living habit;serum ß- Endorphin;

Countries

China

Contacts

Public ContactLijie Yang

Teaching Hospital of Chengdu Universicity of T.C.M

22611808@qq.com+86 13568808063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026